137 related articles for article (PubMed ID: 27316593)
1. Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs.
Velasco-Zamora JA; Gómez-Reyes E; Uscanga L
Rev Gastroenterol Mex; 2016; 81(3):121-5. PubMed ID: 27316593
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
3. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
4. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
5. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
[TBL] [Abstract][Full Text] [Related]
6. Noncompliance with guidelines on proton pump inhibitor prescription as gastroprotection in hospitalized surgical patients who are prescribed NSAIDs.
van den Bemt PM; Chaaouit N; van Lieshout EM; Verhofstad MH
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):857-62. PubMed ID: 27046006
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
8. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
[TBL] [Abstract][Full Text] [Related]
11. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
12. Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.
Montagnani S; Tuccori M; Testi A; Cristofano M; Corona T; Salvadori S; Scarpignato C; Blandizzi C
Int J Clin Pharm; 2016 Aug; 38(4):829-37. PubMed ID: 27003828
[TBL] [Abstract][Full Text] [Related]
13. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
14. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
[TBL] [Abstract][Full Text] [Related]
15. Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.
Erdeljic V; Francetic I; Macolic Sarinic V; Bilusic M; Makar Ausperger K; Huic M; Mercep I
Pharm World Sci; 2006 Oct; 28(5):318-25. PubMed ID: 17111239
[TBL] [Abstract][Full Text] [Related]
16. Management of NSAID-associated peptic ulcer disease.
Melcarne L; García-Iglesias P; Calvet X
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.
Dries AM; Richardson P; Cavazos J; Abraham NS
Aliment Pharmacol Ther; 2009 Sep; 30(6):652-61. PubMed ID: 19573167
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk.
Moore RA; Derry S; Simon LS; Emery P
Pain Pract; 2014 Apr; 14(4):378-95. PubMed ID: 23941628
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
